INTU
58
-3
KO
38
-3
ALLE
37
-4
EMR
71
-3
AAP
35
-9
SO
57
6
HSIC
45
5
TDC
67
-4
EXC
54
3
CB
57
2
EFX
30
-8
F
56
-3
HAL
48
-3
PG
50
2
A
37
-2
MMM
35
-5
INTC
41
4
SCHW
62
-2
NAVI
52
-2
AA
56
15
INTU
58
-3
KO
38
-3
ALLE
37
-4
EMR
71
-3
AAP
35
-9
SO
57
6
HSIC
45
5
TDC
67
-4
EXC
54
3
CB
57
2
EFX
30
-8
F
56
-3
HAL
48
-3
PG
50
2
A
37
-2
MMM
35
-5
INTC
41
4
SCHW
62
-2
NAVI
52
-2
AA
56
15
Financhill
Back

Pacific Biosciences of California Vs. Perspective Therapeutics Industry Stock Comparison

Sell
38

PACB
Pacific Biosciences of California

Last Price:
1.60
Seasonality Move:
21.6%
Sell
30

CATX
Perspective Therapeutics

Last Price:
7.88
Seasonality Move:
40.67%
Sell
38
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.60. The Score for PACB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $7.88. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $7.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 37.01 Sell
Chaikin Money Flow: -17716950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.8 - 2.38) Sell
Bollinger Bands (100): (1.43 - 2.07) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 19.21 Sell
Chaikin Money Flow: -1814221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.47 - 12.81) Sell
Bollinger Bands (100): (11.15 - 14.37) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.19 Sell
20-day SMA: 2.11 Sell
50-day SMA: 1.91 Sell
200-day SMA: 2.5 Sell
8-day EMA: 2.04 Sell
20-day EMA: 2.08 Sell
50-day EMA: 1.95 Sell
200-day EMA: 3.05 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.48 Sell
20-day SMA: 11.39 Sell
50-day SMA: 12.61 Sell
200-day SMA: 12.8 Sell
8-day EMA: 10.03 Sell
20-day EMA: 11.13 Sell
50-day EMA: 12.15 Sell
200-day EMA: 11.67 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.17 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.33 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):